Aclarion, Inc.
ACON- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001635077
In the last 90 days, Aclarion, Inc. insiders filed 6 open-market purchases and 0 sales; 15 institutions reported holding it in 13F filings for Q2 2026, worth $332.1K in total; no superinvestor holds it.
Other share classesACONW
Q3 2024 vs. Q2 2024
How the institutions holding Aclarion, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 9 | 9 | 0 |
| Shares | 329.3K | 372.9K | +43.6K (+13.2%) |
| Value | $94.2K | $68.4K | −$25.8K (−27.4%) |
New holders (2)
Institutions that held Aclarion, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 14,153 | $2.60K | 0.00% |
| Jane Street Group, LLC | 12,239 | $2.25K | 0.00% |
Sold out (2)
Institutions that held Aclarion, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Citadel Advisors LLC | 28,839 | $8.24K |
| Ground Swell Capital, LLC | 12,947 | $3.70K |